article
not require embedded backbone nitrogen functionalities that seem 14. Rezai, T., Yu, B., Millhauser, G.L., Jacobson, M.P. & Lokey, R.S. Testing the
conformational hypothesis of passive membrane permeability using synthetic
to be essential for previously reported biomimetic variants of this
cyclic peptide diastereomers. J. Am. Chem. Soc. 128, 2510–2511 (2006).
transformation. Taken together, the reactions showed excellent
15. Kwon, Y.-U. & Kodadek, T. Quantitative comparison of the relative cell
functional group tolerance and were compatible with various cyclo-
permeability of cyclic and linear peptides. Chem. Biol. 14, 671–677 (2007).
ities in the products.
16. McGrath, N.A., Brichacek, M. & Njardarson, J.T. A graphical journey of
innovative organic architectures that have improved our lives. J. Chem. Educ.
87, 1348–1349 (2010).
17. Illuminati, G. & Mandolini, L. Ring closure reactions of bifunctional chain
molecules. Acc. Chem. Res. 14, 95–102 (1981).
cules derived from medium-ring scaffolds 6, 7 and 52–82 have
structural and physicochemical properties that recapitulate those
found in naturally occurring benzannulated medium rings. Indeed,
the scaffolds obtained by ODRE show key structural features
found in natural products, such as the benzooxocane framework
of heliannuol A1 (55); the aryl ether linkage in brazilone2 (6–8);
ages in steganacin7, rhazinilam8 and various ellagitannins6 (78).
Downstream modifications of ODRE products such as olefin
dihydroxylation provide additional structures that present the polar
and stereochemically rich motifs found in benzannulated medium-
ring natural products. Thus, these scaffolds probe attractive areas
of chemical space that are not currently targeted by high-profile
synthetic drugs and related libraries. Biological evaluation of the
resulting libraries is ongoing and will be reported in due course.
18. Bauer, R.A., Wurst, J.M. & Tan, D.S. Expanding the range of ′druggable′
targets with natural product–based libraries: an academic perspective. Curr.
Opin. Chem. Biol. 14, 308–314 (2010).
19. Fürstner, A. & Mueller, C. Total synthesis of aspercyclide C. Chem. Commun.
(Camb.) 5583–5585 (2005).
20. Pospíšil, J., Mueller, C. & Fürstner, A. Total synthesis of the aspercyclides.
Chemistry 15, 5956–5968 (2009).
21. Stefinovic, M. & Snieckus, V. Connecting directed ortho metalation and olefin
metathesis strategies. Benzene-fused multiring-sized oxygen heterocycles.
First syntheses of radulanin A and helianane. J. Org. Chem. 63, 2808–2809
(1998).
22. Kishuku, H., Shindo, M. & Shishido, K. Enantioselective total synthesis of
(–)-heliannuol A. Chem. Commun. (Camb.) 350–351 (2003).
23. Biswas, B., Sen, P.K. & Venkateswaran, R.V. Bargellini condensation of
coumarins. Expeditious route to [o-(carboxyvinyl)phenoxy]isobutyric acids
and application to the synthesis of sesquiterpenes helianane, heliannuol A
and heliannuol C. Tetrahedron 63, 12026–12036 (2007).
24. Macías, F.A., Chinchilla, D., Molinillo, J.M.G., Fronczek, F.R. & Shishido, K.
A stereoselective route towards heliannuol A. Tetrahedron 64, 5502–5508 (2008).
25. Sabui, S., Ghosh, S., Sarkar, D. & Venkateswaran, R.V. Expeditious synthesis
of helianane and C-10 halogenated heliananes employing ring-closing
metathesis. Tetrahedr. Lett. 50, 4683–4684 (2009).
received 28 July 2011; accepted 22 October 2012;
published online 18 November 2012
26. Deb, I., John, S. & Namboothiri, I.N.N. Synthesis of benzo-fused medium
ring cyclic ethers via a Michael addition–ring closing metathesis strategy
involving nitroaliphatic compounds. Tetrahedron 63, 11991–11997 (2007).
27. Souers, A.J., Virgilio, A.A., Rosenquist, A., Fenuik, W. & Ellman, J.A.
Identification of a potent heterocyclic ligand to somatostatin receptor subtype
5 by the synthesis and screening of β-turn mimetic libraries. J. Am. Chem.
Soc. 121, 1817–1825 (1999).
28. Spring, D.R., Krishnan, S., Blackwell, H.E. & Schreiber, S.L. Diversity-oriented
synthesis of biaryl-containing medium rings using a one bead/one stock
solution platform. J. Am. Chem. Soc. 124, 1354–1363 (2002).
29. Khadem, S. et al. A solution- and solid-phase approach to
tetrahydroquinoline-derived polycyclics having a 10-membered ring. J. Comb.
Chem. 6, 724–734 (2004).
30. Brown, N. et al. Design and synthesis of medium-ring lactam libraries
inspired by octalactin A. A convergent-divergent approach. J. Comb. Chem.
10, 628–631 (2008).
meTHODS
references
1. Macías, F.A., Varela, R.M., Torres, A., Molinillo, J.M.G. & Fronczek, F.R.
Allelopathic studies on cultivar species. 2. Novel sesquiterpene from
bioactive fractions of cultivar sunflowers. Tetrahedr. Lett. 34, 1999–2002
(1993).
2. Shimokawa, T., Kinjo, J., Yamahara, J., Yamasaki, M. & Nohara, T. Two novel
aromatic compounds from Caesalpinia sappan. Chem. Pharm. Bull. (Tokyo)
33, 3545–3547 (1985).
31. Marcaurelle, L.A. et al. An aldol-based build/couple/pair strategy for the
synthesis of medium- and large-sized rings: discovery of macrocyclic histone
deacetylase inhibitors. J. Am. Chem. Soc. 132, 16962–16976 (2010).
32. Roxburgh, C.J. Syntheses of medium sized rings by ring expansion reactions.
Tetrahedron 49, 10749–10784 (1993).
3. Singh, S.B. et al. Aspercyclide A–C, three novel fungal metabolites from
Aspergillus sp. as inhibitors of high-affinity IgE receptor. Tetrahedr. Lett. 45,
7605–7608 (2004).
4. Shirataki, Y., Tagaya, Y., Yokoe, I. & Komatsu, M. Studies on the constituents
of Sophora species. Part 21. Sophoraside A, a new aromatic glycoside from
the roots of Sophora japonica. Chem. Pharm. Bull. (Tokyo) 35, 1637–1640
(1987).
33. Hesse, M. Ring Enlargement in Organic Chemistry (VCH, Weinheim, 1991).
34. Barton, D.H.R. Some studies in the biogenesis of plant products. Pure Appl.
Chem. 9, 35–48 (1964).
5. Fu, X. et al. Flavanone and chalcone derivatives from Cryptocarya kurzii.
J. Nat. Prod. 56, 1153–1163 (1993).
35. Battersby, A.R., Bhatnagar, A.K., Hackett, P., ornber, C.W. & Staunton, J.
Synthesis of protostephanine by a route related to the biosynthetic pathway.
Chem. Commun. 1214–1215 (1968).
6. Quideau, S. & Feldman, K.S. Ellagitannin chemistry. Chem. Rev. 96, 475–504
(1996).
36. Bhakuni, D.S. & Jain, S. e biosynthesis of laurifinine. Tetrahedron 37,
3171–3174 (1981).
7. Kupchan, S.M. et al. Tumor inhibitors. LXXX. Steganacin and steganangin,
novel antileukemic lignan lactones from Steganotaenia araliacea. J. Am.
Chem. Soc. 95, 1335–1336 (1973).
37. euns, H.G. et al. Neodihydrothebaine and bractazonine, two dibenz[d,f]
azonine alkaloids of Papaver bracteatum. Phytochemistry 23, 1157–1166
(1984).
8. Abraham, D.J., Rosenstein, R.D., Lyon, R.L. & Fong, H.H.S. e structure
elucidation of rhazinilam, a new class of alkaloids from the Apocynaceae, by
X-ray analysis. Tetrahedr. Lett. 13, 909–912 (1972).
38. Marino, J.P. & Samanen, J.M. Biogenetic-type approach to homoerythrina
alkaloids. J. Org. Chem. 41, 179–180 (1976).
9. Majhi, T.P., Achari, B. & Chattopadhyay, P. Advances in the synthesis and
biological perspectives of benzannulated medium ring heterocycles.
Heterocycles 71, 1011–1052 (2007).
39. Kupchan, S.M., Kim, C.-K. & Lynn, J.T. Biomimetic synthesis of a key
Erythrina alkaloid precursor. J. Chem. Soc. Chem. Commun. 86 (1976).
40. Kupchan, S.M., Dhingra, O.P. & Kim, C.-K. New biogenetic-type approach
to Cephalotaxus alkaloids. J. Chem. Soc. Chem. Commun. 847–848 (1977).
41. Kopp, F., Stratton, C.F., Akella, L.B. & Tan, D.S. A diversity-oriented synthesis
approach to macrocycles via oxidative ring expansion. Nat. Chem. Biol. 8,
358–365 (2012).
10. Khan, A.R. et al. Lowering the entropic barrier for binding conformationally
flexible inhibitors to enzymes. Biochemistry 37, 16839–16845 (1998).
11. Benfield, A.P. et al. Ligand preorganization may be accompanied by entropic
penalties in protein-ligand interactions. Angew. Chem. Int. Ed. Engl. 45,
6830–6835 (2006).
42. Miller, B. Too many rearrangements of cyclohexadienones. Acc. Chem. Res. 8,
245–256 (1975).
12. Udugamasooriya, D.G. & Spaller, M.R. Conformational constraint in protein
ligand design and the inconsistency of binding entropy. Biopolymers 89,
653–667 (2008).
43. Marino, J.P. & Samanen, J.M. Chemistry of prohomoerythrinadienone I.
Tetrahedr. Lett. 14, 4553–4556 (1973).
44. Hosomi, A. Characteristics in the reactions of allylsilanes and their applications
to versatile synthetic equivalents. Acc. Chem. Res. 21, 200–206 (1988).
13. Veber, D.F. et al. Molecular properties that influence the oral bioavailability of
drug candidates. J. Med. Chem. 45, 2615–2623 (2002).
8
nature CHeMICaL BIOLOGY | AdvAnce online publicAtion | www.nature.com/naturechemicalbiology